NcodiN | $18,456,480 | (Nov 21, 2025)
Voio | $8,600,000 | (Nov 21, 2025)
Stuut | $29,500,000 | (Nov 21, 2025)
Booster Therapeutics
Germany
- Berlin
- 11/10/2024
- Seed
- $15,000,000
Booster Therapeutics is pioneering a new class of medicines that activate proteasomes (the cell’s natural quality control machinery) to treat a range of complex indications. The company is developing a multi-disease pipeline, with an initial focus on neurodegenerative diseases associated with impaired proteasome function.
- Industry Biotechnology Research
- Website https://www.boostertx.com/
- LinkedIn https://www.linkedin.com/company/booster-therapeutics/
Related People
Diogo R. FelecianoCo Founder
Germany -
Berlin, Berlin
My mission is to revolutionize patient health by spearheading the development of game-changing and innovative treatments.
In 2020, founded Booster Therapeutics with the aim of discovering and developing a new class of drugs that can potentially treat various diseases where conventional treatment options fall short.
With over a decade of expertise in life sciences acquired through academic research, venture capital, and biotech, I have specialized knowledge in R&D, company building, and aging/neuro/ocular biology.
Made Card | $8,000,000 | (Nov 21, 2025)
Poly(US) | $8,000,000 | (Nov 21, 2025)
Runlayer | $11,000,000 | (Nov 21, 2025)
AI Proteins | $41,500,000 | (Nov 21, 2025)
Automat | $15,500,000 | (Nov 21, 2025)
EQORE | $1,700,000 | (Nov 21, 2025)
Poppy Flowers | $2,700,000 | (Nov 21, 2025)
WellBeam Inc | $10,000,000 | (Nov 21, 2025)
Revenium | $13,500,000 | (Nov 21, 2025)